InsiderClue
← All stocks

MADRIGAL PHARMACEUTICALS, INC.

MDGL Net selling
CIK 0001157601 #854 in the set updated 17 Sep 2026
Bought (120 mo)
$141.04M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$792.30M
$17.40M on a plan · $291.32M straight out of an exercise
Sold at will
$483.58M
56 of 544 sales
Net
−$651.26M
−$342.54M against sales at will

By person

23 insiders · 766 transactions
117×

Bill Sibold holds 117 times base salary in stock. $108.04M of shares against $918.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Bill Sibold last reported holding, valued at $546.38, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
CRAVES FRED B
Director
$249.39K (3)
$222.54M (34)
−$222.29M
361,076
1.56%
$197.28M
−94.3%
BAY CITY CAPITAL LLC entity
10% owner
—
$210.34M (7)
−$210.34M
1,261
0.0055%
$688.98K
−100.0%
FRIEDMAN PAUL A
Director
$967.52K (2)
$147.39M (105) scheduled
−$146.42M
842,704
3.65%
$460.43M
−4.5%
BAKER BROS. ADVISORS LP entity
Director
$139.67M (192)
—
+$139.67M
1,948,876
8.44%
$1.06B
+45.3%
Taub Rebecca
Director
—
$89.31M (92) scheduled
−$89.31M
1,108,207
4.80%
$605.50M
+9.0%
BATE KENNETH
Director
—
$27.02M (43) scheduled
−$27.02M
2,627
0.0114%
$1.44M
—
Levy Richard S
Director
$145.80K (20)
$20.04M (47) scheduled
−$19.89M
22,469
0.0973%
$12.28M
—
Sibold William John
President and CEO
—
$18.86M (42)
−$18.86M
197,746
0.8559%
$108.04M
—
Daly James M
Director
—
$13.59M (19) scheduled
−$13.59M
3,081
0.0133%
$1.68M
—
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
—
$11.25M (30) scheduled
−$11.25M
5,789
0.0251%
$3.16M
—
Sukhija Remy
Chief Commercial Officer
—
$8.22M (18) scheduled
−$8.22M
15,001
0.0649%
$8.20M
—
Lynch Brian Joseph
SVP and General Counsel
—
$7.63M (32) scheduled
−$7.63M
17,691
0.0766%
$9.67M
—
Dier Mardi
EVP and CFO
—
$4.49M (31) scheduled
−$4.49M
12,490
0.0541%
$6.82M
+40.7%
MILLIGAN DAVID V
Director
—
$3.57M (2)
−$3.57M
0
0.0000%
$0.00
—
Schneebaum Marc R
Chief Financial Officer
—
$2.90M (1) scheduled
−$2.90M
41,668
0.1803%
$22.77M
−4.9%
Huntsman Carole
Chief Commercial Officer
—
$2.65M (25) scheduled
−$2.65M
12,692
0.0549%
$6.93M
—
Kelley Shannon T
General Counsel
—
$1.54M (14) scheduled
−$1.54M
11,474
0.0497%
$6.27M
+314.7%
Soergel David
Chief Medical Officer
—
$951.98K (2) scheduled
−$951.98K
10,033
0.0434%
$5.48M
—
Howarth Alex G.
Chief Financial Officer
—
—
—
18,737
0.0811%
$10.24M
—
Thakkar Rita
Chief Accounting Officer
—
—
—
2,398
0.0104%
$1.31M
—
FOUSE JACQUALYN A
Director
—
—
—
1,551
0.0067%
$847.43K
—
Brennan Daniel J.
Director
—
—
—
1,371
0.0059%
$749.08K
—
REED JOHN C
Director
—
—
—
647
0.0028%
$353.51K
—

Individual transactions

35
Insider
Date
Role
Action
Shares
Price
Amount
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
9,362
$392.24
$3.67M
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
862
$392.24
$338.11K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
2,506
$389.89
$977.06K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
231
$389.89
$90.06K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
366
$389.00
$142.37K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
34
$389.00
$13.23K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
4,441
$387.07
$1.72M
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
409
$387.07
$158.31K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
13,545
$385.06
$5.22M
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
1,248
$385.06
$480.55K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
4,049
$383.79
$1.55M
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
373
$383.79
$143.15K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
2,838
$382.82
$1.09M
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
262
$382.82
$100.30K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
1,136
$382.29
$434.28K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
105
$382.29
$40.14K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
9,477
$381.12
$3.61M
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
873
$381.12
$332.72K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
1,919
$380.78
$730.72K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
176
$380.78
$67.02K
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
5,209
$380.44
$1.98M
BAKER BROS. ADVISORS LP
20 Aug 2025
Director
Buy indirect
480
$380.44
$182.61K
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
10,128
$372.16
$3.77M
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
933
$372.16
$347.22K
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
5,494
$371.01
$2.04M
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
506
$371.01
$187.73K
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
2,747
$369.34
$1.01M
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
253
$369.34
$93.44K
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
1,419
$368.84
$523.38K
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
131
$368.84
$48.32K
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
4,798
$367.77
$1.76M
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
442
$367.77
$162.55K
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
2,289
$366.30
$838.46K
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
211
$366.30
$77.29K
BAKER BROS. ADVISORS LP
18 Aug 2025
Director
Buy indirect
2,772
$363.75
$1.01M
Showing 250 of 766 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 247
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 19
Sales on a Rule 10b5-1 plan 87
Sales straight out of an exercise 401
Sales at will 56
Transactions with no price 0
Shares from compensation/vesting 8,643,657
Sales filed before the plan box existed 18
History held since 24 Oct 2016